This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of ...

Americans’ trust in artificial intelligence is declining even as global advances in the field accelerate. That points to a ...

Ravi Shankar was speaking with a prospective customer recently who was facing the challenge of integrating data from 300 ...

In 2023, 48 states and the District of Columbia reported 2,770 human arboviral disease cases, with West Nile Virus (WNV) being the most common, according to research published in the June 12 issue of ...

The brain isn't a computer—it's a dynamic, adaptable system shaped by evolution. It's emotional, contextual, and designed for ...

On his second day in office, President Donald Trump labeled O.F.C.C.P.’s efforts to enforce the 1964 Civil Rights Act illegal ...

New findings reveal mirvetuximab soravtansine significantly improves outcomes in patients with recurrent platinum-sensitive ...

Positive phase I/II data presented at the 2025 International Society on Thrombosis and Haemostasis (ISTH) Congress show NXT007 achieved no bleeds requiring treatment in the highest dose groups in ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced simultaneous presentation and publication of updated data from the Phase 1/2 portion of the Phase 1/2/3 FORWARD-101 clinical trial of ...

The GCAptAIN study did not meet its primary endpoint of sustained remission at Week 52 in adults with newly diagnosed or relapsing GCA1 ...